dysfunction. It is usually recognized during childhood. The over-the-counter synthetic beta-carotene product Lumitene is FDA approved for photoprotection in this disease. Antihistamines may also be used to reduce symptoms.
Carotenoid deficiency
Although consumption of provitamin A carotenoids (alpha-carotene, betacarotene, and beta-cryptoxanthin) can prevent vitamin A deficiency, no overt deficiency symptoms have been identified in people consuming low-carotenoid diets if they consume adequate vitamin A. After reviewing the published scientific research, the Food and Nutrition Board of the Institute of Medicine (IOM) concluded that the existing evidence in 2000 was insufficient to establish a recommended dietary allowance (RDA) or adequate intake (AI) for carotenoids.
C Cataract prevention
Study results of beta-carotene supplementation for cataract prevention are conflicting. Further well-designed clinical trials are needed before a conclusion can be drawn.
C Chemotherapy toxicity
Observational research suggests that greater dietary intake of beta-carotene may lower the incidence of adverse effects in children undergoing chemotherapy for lymphoblastic leukemia. However, in theory high-dose antioxidants may interfere with the activity of some chemotherapy drugs or radiation therapy. Therefore, individuals undergoing cancer treatment should speak with their oncologist if they are taking or considering the use of high dose antioxidants. Additional evidence is needed in this area before a clear conclusion can be drawn.
C Chronic obstructive pulmonary disease (COPD)
The prevalence of bronchitis and shortness of breath in male smokers with chronic obstructive pulmonary disorder (COPD) seems to be lower in those patients who consume a diet containing high amounts of beta-carotene. However, beta-carotene supplements have not been proven to benefit COPD and may actually increase cancer rates in smokers.
C Cystic fibrosis
Individuals with cystic fibrosis may be deficient in beta-carotene and vitamin E, and it has been suggested that they may be more susceptible to oxidative damage. Theoretically, these patients may benefit from beta-carotene supplementation. Further research is needed before a conclusion can be drawn.
Exercise-induced asthma prevention
Based on preliminary evidence, taking a mixture of beta-carotene isomers orally may prevent exercise-induced asthma. However, because synthetic betacarotene has not been well tested for this indication, the difference between the activities of the two supplements cannot be deduced. Further research is needed before a recommendation can be made.
C

Immune system enhancement
Preliminary research of beta-carotene for immune system maintenance or stimulation shows mixed results. Further research is needed before a conclusion can be drawn.
C Macular degeneration
Taking beta-carotene and other antioxidants has been proposed to help prevent or delay progression of age-related macular degeneration. However, other dietary carotenoids such as lycopene, lutein, and zeaxanthin may provide greater protection from radiation and oxidative damage in the retina than beta-carotene. Further research is needed before a conclusion can be drawn.
C Oral leukoplakia
Taking beta-carotene orally seems to induce remission in patients with oral leukoplakia. Further research is needed to confirm these results.
C Osteoarthritis
Beta-carotene supplementation does not appear to prevent osteoarthritis, but it might slow progression of the disease. Well-designed clinical trials are needed before a conclusion can be drawn.
C Polymorphous light eruption (PLE)
Beta-carotene has been used for PLE. Additional study is needed in this area. C
Pregnancy-related complications
All-trans beta-carotene (synthetic beta-carotene) taken weekly before, during, and after pregnancy may reduce pregnancy-related mortality, night blindness, post partum diarrhea and fever. A regular intake of a micronutrient supplement at a nutritional dose may be sufficient to improve micronutrient status of apparently healthy pregnant women and could prevent low birth weight of newborn. However, further research is necessary to consolidate the evidence in this area C before a clear recommendation can be made.
UV-induced erythema prevention/sunburn
A combination of antioxidants may help protect the skin against irradiation. Longterm supplementation with beta-carotene may reduce UV-induced erythema, and appears to modestly reduce the risk of sunburn in individuals who are sensitive to sun exposure. However, beta-carotene is unlikely to have much effect on sunburn risk in most people.
C Abdominal aortic aneurysm (AAA) prevention
Long-term supplementation with alpha-tocopherol or beta-carotene has been shown not to have a protective or preventive effect in male smokers with large AAAs.
D Alzheimer's disease
Intake of dietary or supplemental beta-carotene has been shown not to have any effect on Alzheimer's disease risk.
D Angioplasty
There is some concern that when antioxidant vitamins, including beta-carotene, are used together they might have harmful effects in patients after angioplasty. Additional research is needed to determine the effect of beta-carotene specifically. Supplements containing these vitamins should be avoided immediately before and following angioplasty without the recommendation of a qualified healthcare professional.
D Birthmark/mole (dysplastic nevi) prevention
Beta-carotene has been shown not to reduce the development of new moles in patients with numerous atypical moles.
D Cancer
While diets high in fruits and vegetables rich in beta-carotene have been shown to potentially reduce the incidence of certain cancers, results from randomized controlled trials with oral supplements do not support this claim.
There is some concern that beta-carotene metabolites with pharmacological activity can accumulate and potentially have cancer causing (carcinogenic) effects. A higher, statistically significant incidence of lung cancer in male smokers who took beta-carotene supplements has been discovered. Beta-carotene/vitamin A supplements may have an adverse effect on the incidence of lung cancer and on the risk of death in smokers and asbestos exposed people or in those who ingest significant amounts of alcohol. In addition, high-dose antioxidants theoretically may interfere with the activity of some chemotherapy drugs or radiation therapy. Therefore, individuals undergoing cancer treatment should speak with their oncologist if they are taking or considering the use of high dose antioxidants.
Beta-carotene in the amounts normally found in food does not appear to have this adverse effect.
D Cardiovascular disease
Although several studies suggest that diets high in fruits and vegetables containing beta-carotene appear to reduce the risk of cardiovascular disease, most randomized controlled trials with oral supplements of beta-carotene have not supported these claims.
A Science Advisory from the American Heart Association states that the evidence does not justify use of antioxidants such as beta-carotene for reducing the risk of cardiovascular disease.
D Helicobacter pylori bacteria eradication
Infection with Helicobacter pylori bacteria in the gut can lead to gastric ulcers. Dietary supplementation with beta-carotene has not been found to be effective for this indication.
D Mortality reduction
Patients given beta-carotene supplements show no reduction in relative mortality rates from all causes based on most available data.
D Postoperative tissue injury prevention
Study results conclude that peri-operative supplementation with antioxidant micronutrients has limited effects on strength and physical function following major elective surgery.
D Stroke
Taking all-trans beta-carotene (synthetic beta-carotene) orally has been reported to have no effect on the overall incidence of stroke in male smokers. Additionally, there is some evidence that beta-carotene actually increases the risk of intracerebral hemorrhage by 62% in patients who also drink alcohol. Acute respiratory infections, anemia, angina pectoris, asbestosis, benign breast disease, bone marrow transplantation, bronchial asthma (exercise-induced bronchoconstriction symptoms in young athletes), bronchopulmonary dysplasia in premature infants, chronic atrophic gastritis, chronic myeloid leukemia, diabetes, Graves' disease, high cholesterol, HIV, improving lung function, iron deficiency prevention, low birth weight (prevention), multiple myeloma, nasal polyposis, nutrition supplementation (during alcohol rehabilitation ), sepsis, Streptococcal infections (group A), supratentorial glioblastoma, weight loss (HIV, post-partum).
The below doses are based on scientific research, publications, traditional use, or expert opinion. Many herbs and supplements have not been thoroughly tested, and safety and effectiveness may not be proven. Brands may be made differently, with variable ingredients, even within the same brand. The below doses may not apply to all products. You should read product labels, and discuss doses with a qualified healthcare provider before starting therapy.
General:
Formulations: Beta-carotene supplements are available in both oil matrix gelatin capsules and water-miscible forms. Some clinical trials have used water-miscible betacarotene (10%) beadlets. The water miscible form seems to produce a significantly higher response in plasma beta-carotene (approximately 47% to 50%) than oil matrix gelatin capsules. Oral dosage is available in capsules (U.S. and Canada), tablets (U.S. and Canada), and chewable tablets (Canada). Dietary intake: Consuming 5 servings of fruit and vegetables daily provides 6-8 milligrams of beta-carotene. Beta-carotene requires some dietary fat for absorption, but supplemental beta-carotene is similarly absorbed when taken with high-fat or low-fat meals. 1,800 micrograms of beta-carotene has been reported to maintain adequate vitamin A levels.
Consensus recommendations:
The American Heart Association recommends obtaining antioxidants, including beta-carotene, from a diet high in fruits, vegetables and whole grains rather than through supplements, until more information is available from randomized clinical trials. 15-180 milligrams taken by mouth of supplemental beta-carotene has been studied for various indications.
Children (younger than 18 years):
There is insufficient available data to recommend high-dose oral (by mouth) supplementation in children. 
Allergies
People who are sensitive to beta-carotene, vitamin A or any other ingredients in betacarotene products should avoid supplemental use.
Side Effects and Warnings
Supplemental beta-carotene in children should be limited to specific medical indications. There is insufficient reliable information available about the safety of large doses of betacarotene in pregnant or breastfeeding women. Supplemental beta-carotene may increase the risk of lung cancer, prostate cancer, intracerebral hemorrhage, and cardiovascular and total mortality in people who smoke cigarettes or have a history of high-level exposure to asbestos. Beta-carotene from foods does not seem to have this effect.
In people who smoke, beta-carotene may increase cardiovascular mortality. In men who smoke and have had a prior myocardial infarction (MI), the risk of fatal coronary heart disease increases by as much as 43% with low doses of beta-carotene. There is some evidence that beta-carotene in combination with selenium, vitamin C and vitamin E might lower high-density lipoprotein 2 (HDL2) cholesterol levels. HDL levels are protective so this is considered to be a negative effect. Dizziness, reversible yellowing of palms, hands, or soles of feet and to a lesser extent the face (called carotenoderma) can occur with high doses of beta-carotene. Loose stools, diarrhea, unusual bleeding or bruising and joint pain have been reported. 
Pregnancy and Breastfeeding
Interactions with Herbs and Dietary Supplements
Consumption of a natural carotenoid mixture has been shown to lower the increase in oxidative stress induced by the fish oil. This carotenoid mixture may also enhance the plasma triglyceride-lowering effect of the fish oil. Iron supplementation in infants with marginal vitamin A status has led to lower plasma vitamin A concentrations and greater vitamin A liver stores. Some researchers recommend that iron supplementation in infants should be accompanied by measures to improve vitamin A status. Beta-carotene supplementation has been shown to lower serum lutein concentrations. Lutein from food sources does not seem to result in the decrease in beta-carotene concentrations that accompanies administration of lutein supplements. Plant sterols have been shown to reduce beta-carotene bioavailability in some studies and not to have a significant effect in others. The effects on cholesterol levels are also unproven. Supplementation of beta-carotene may decrease the vitamin E concentration in tissues.
